Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis

被引:11
作者
Yu, Yun [1 ]
Liu, Liang [1 ]
Hu, Long-Long [1 ]
Yu, Ling-Ling [2 ]
Li, Jun-Pei [1 ]
Rao, Jing-an [1 ]
Zhu, Ling-Juan [1 ]
Liang, Qian [1 ]
Zhang, Rong-Wei [3 ]
Bao, Hui-Hui [1 ]
Cheng, Xiao-Shu [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Nanchang, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 2, Dept Rehabil, Nanchang, Jiangxi, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 2, Dept Rheumatol, Nanchang, Jiangxi, Peoples R China
关键词
Systemic lupus erythematosus; bioinformatics; differentially expressed genes; tissue-specific gene expression; biomarkers; CHEMOKINE RECEPTORS; AUTOIMMUNE-DISEASE; DENDRITIC CELLS; GELATINASE-B; BONE-MARROW; SIGNATURE; MATRIX-METALLOPROTEINASE-9; ATHEROSCLEROSIS; MANIFESTATIONS; MODEL;
D O I
10.1080/21655979.2021.1939637
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease involving multiple organs. However, the underlying etiology and mechanisms remain unclear. This study was performed to identify potential therapeutic targets for SLE using bioinformatics methods. First, 584 differentially expressed genes were identified based on the GSE61635 dataset. Tissue-specific analyses, enrichment analyses, and Protein-Protein interaction network were successively conducted. Furthermore, ELISA was performed to confirm the expression levels of key genes in the control and SLE blood samples. The findings revealed that tissue-specific expression of markers of the hematological system (25.5%, 28/110) varied significantly. CCL2, MMP9, and RSAD2 expression was markedly increased in the SLE samples compared with controls. In conclusion, the identified key genes (CCL2, MMP9, and RSAD2) may act as possible therapeutic targets for the treatment of SLE.
引用
收藏
页码:2810 / 2819
页数:10
相关论文
共 44 条
[1]   Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities [J].
Ainiala, H ;
Hietaharju, A ;
Dastidar, P ;
Loukkola, J ;
Lehtimäki, T ;
Peltola, J ;
Korpela, M ;
Heinonen, T ;
Nikkari, ST .
ARTHRITIS AND RHEUMATISM, 2004, 50 (03) :858-865
[2]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[3]   NCBI GEO: archive for functional genomics data sets-10 years on [J].
Barrett, Tanya ;
Troup, Dennis B. ;
Wilhite, Stephen E. ;
Ledoux, Pierre ;
Evangelista, Carlos ;
Kim, Irene F. ;
Tomashevsky, Maxim ;
Marshall, Kimberly A. ;
Phillippy, Katherine H. ;
Sherman, Patti M. ;
Muertter, Rolf N. ;
Holko, Michelle ;
Ayanbule, Oluwabukunmi ;
Yefanov, Andrey ;
Soboleva, Alexandra .
NUCLEIC ACIDS RESEARCH, 2011, 39 :D1005-D1010
[4]   A comparison of normalization methods for high density oligonucleotide array data based on variance and bias [J].
Bolstad, BM ;
Irizarry, RA ;
Åstrand, M ;
Speed, TP .
BIOINFORMATICS, 2003, 19 (02) :185-193
[5]   Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients [J].
Cervera, R ;
Khamashta, MA ;
Font, J ;
Sebastiani, GD ;
Gil, A ;
Lavilla, P ;
Mejía, JC ;
Aydintug, AC ;
Chwalinska-Sadowska, H ;
de Ramón, E ;
Fernández-Nebro, A ;
Galeazzi, M ;
Valen, M ;
Mathieu, A ;
Houssiau, FD ;
Caro, N ;
Alba, P ;
Ramos-Casals, M ;
Ingelmo, M ;
Hughes, GRV .
MEDICINE, 2003, 82 (05) :299-308
[6]   Controversial view of a genetically altered mouse model of focal retinal degeneration [J].
Chu, Xi K. ;
Wang, Yujuan ;
Ardeljan, Daniel ;
Tuo, Jingsheng ;
Chan, Chi-Chao .
BIOENGINEERED, 2013, 4 (03) :130-135
[7]   Estrogen Receptors in Immunity and Autoimmunity [J].
Cunningham, Melissa ;
Gilkeson, Gary .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2011, 40 (01) :66-73
[8]   Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus [J].
Doedens, John R. ;
Jones, Wendell D. ;
Hill, Kay ;
Mason, Michael J. ;
Gersuk, Vivian H. ;
Mease, Philip J. ;
Dall'Era, Maria ;
Aranow, Cynthia ;
Martin, Richard W. ;
Cohen, Stanley B. ;
Fleischmann, Roy M. ;
Kivitz, Alan J. ;
Burge, Daniel J. ;
Chaussabel, Damien ;
Elkon, Keith B. ;
Posada, James A. .
JOURNAL OF IMMUNOLOGY, 2016, 197 (07) :2854-2863
[9]   Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset [J].
Dominguez-Gutierrez, Paul R. ;
Ceribelli, Angela ;
Satoh, Minoru ;
Sobel, Eric S. ;
Reeves, Westley H. ;
Chan, Edward K. L. .
ARTHRITIS RESEARCH & THERAPY, 2014, 16 (01)
[10]   Ultraviolet light converts propranolol, a nonselective β-blocker and potential lupus-inducing drug, into a proinflammatory AhR ligand [J].
Dorgham, Karim ;
Amoura, Zahir ;
Parizot, Christophe ;
Arnaud, Laurent ;
Frances, Camille ;
Pionneau, Cedric ;
Devilliers, Herve ;
Pinto, Sandra ;
Zoorob, Rima ;
Miyara, Makoto ;
Larsen, Martin ;
Yssel, Hans ;
Gorochov, Guy ;
Mathian, Alexis .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (11) :3174-3187